臨床試験管理システム（CTMS）市場：コンポーネント別、タイプ別、提供形態別、エンドユーザー別-2030年までの世界予測

臨床試験管理システム（CTMS）市場は、2023～2030年にかけてCAGR 13.5%で成長し、2030年には35億9,000万米ドルに達すると予測されます。

本レポートは、臨床試験管理システムの市場シナリオに関する広範な2次調査と1次調査、詳細な分析を経て、主要な業界促進要因・阻害要因・課題・機会の分析から構成されています。臨床試験数の急増、医療IT導入の増加、政府支援の高まりが市場促進要因となっています。さらに、AIベースのCTMSの採用が増加していることは、市場拡大のためのより良い成長機会を提供する可能性が高いです。さらに、統合型CTMSソリューションの動向の高まりも市場成長を後押しするとみられます。しかし、高度なデジタルソリューションを扱える熟練した医療専門家の不足は、CTMS市場の成長にとって大きな課題となっています。

目次

第1章 イントロダクション

第2章 調査手法

• 本調査の前提条件
• 研究の限界

第3章 エグゼクティブ概要

第4章 市場洞察

• イントロダクション
• 促進要因
  • 臨床試験数の急増
  • 医療ITソリューションの採用増加
  • 政府支援の増加
• 抑制要因
  • 予算の制約
  • データプライバシーとセキュリティに対する懸念
• ビジネス機会
  • 人工知能（AI）ベースのCTMS
• 課題
  • 熟練した専門家の不足
• COVID-19がCTMS市場に与える影響
• 動向：統合型CTMSソリューションへの企業の傾斜

第5章 臨床試験管理システム（CTMS）市場：コンポーネント別

• イントロダクション
• ソフトウェア
• サービス

第6章 臨床試験管理システム（CTMS）市場：タイプ別

• イントロダクション
• エンタープライズベース
• サイトベース

第7章 臨床試験管理システム（CTMS）市場：提供形態別

• イントロダクション
• ウェブベースCTMS
• クラウドベースCTMS
• オンプレミス型CTMS

第8章 臨床試験管理システム（CTMS）市場：エンドユーザー別

• イントロダクション
• 開発業務受託機関（CRO）
• 製薬・バイオテクノロジー企業
• 医療機器企業
• その他

（注：その他のエンドユーザーには、病院、学術機関、動物医療企業などが含まれる）

第9章 臨床試験管理システム（CTMS）市場：地域別

• イントロダクション
• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • フランス
  • 英国
  • イタリア
  • スペイン
  • その他の欧州
• アジア太平洋
  • 日本
  • 中国
  • インド
  • その他のアジア太平洋
• ラテンアメリカ
  • ブラジル
  • メキシコ
  • その他のラテンアメリカ
• 中東・アフリカ

第10章 競合情勢

• イントロダクション
• 主要成長戦略
• 市場シェア分析（2022年）

第11章 企業プロファイル企業プロファイル（事業概要、財務スナップショット、製品ポートフォリオ、戦略的展開）

• Oracle Corporation（米国）
• SimpleTrials（米国）
• LABORATORY CORPORATION OF AMERICA HOLDINGS（米国）
• Wipro Limited（インド）
• Advarra, Inc.（米国）
• RealTime Software Solutions, LLC（米国）
• Datatrak International, Inc.（米国）
• Clario（米国）
• Dassault Systemes（フランス）
• Veeva Systems Inc.（米国）
• PHARMASEAL（英国）
• MasterControl Inc.（米国）
• Calyx（米国）
• IQVIA HOLDINGS INC.（米国）
• DSG, Inc.（米国）
• その他

第12章 付録

LIST OF TABLES

• Table 1 Global Clinical Trial Management System Market: Impact Analysis of Market Drivers (2024-2030)
• Table 2 Global Clinical Trial Management System Market: Impact Analysis of Market Restraints (2024-2030)
• Table 3 Global Clinical Trial Management System Size, by Component, 2021-2030 (USD Million)
• Table 4 Global Clinical Trial Management System Software Market Size, by Country/Region, 2021-2030 (USD Million)
• Table 5 Global Clinical Trial Management System Service Market Size, by Country/Region, 2021-2030 (USD Million)
• Table 6 Global Clinical Trial Management System Size, by Type, 2021-2030 (USD Million)
• Table 7 Global Clinical Trial Management System Enterprise-based Market Size, by Country/Region, 2021-2030 (USD Million)
• Table 8 Global Clinical Trial Management System Site-based Market Size, by Country/Region, 2021-2030 (USD Million)
• Table 9 Global Clinical Trial Management System Size, by Mode of Delivery, 2021-2030 (USD Million)
• Table 10 Global Web-based Clinical Trial Management System Market Size, by Country/Region, 2021-2030 (USD Million)
• Table 11 Global Cloud-based Clinical Trial Management System Market Size, by Country/Region, 2021-2030 (USD Million)
• Table 12 Global On-premise Clinical Trial Management System Market Size, by Country/Region, 2021-2030 (USD Million)
• Table 13 Global Clinical Trial Management System Size, by End User, 2021-2030 (USD Million)
• Table 14 Global Clinical Trial Management System Market Size for Contract Research Organizations, by Country/Region,2021-2030 (USD Million)
• Table 15 Global Clinical Trial Management System Market Size for Pharmaceutical & Biotechnology Companies, by Country/Region, 2021-2030 (USD Million)
• Table 16 Global Clinical Trial Management System Market Size for Medical Device Companies, by Country/Region, 2021-2030 (USD Million)
• Table 17 Global Clinical Trial Management System Market Size for Other End Users, by Country/Region, 2021-2030 (USD Million)
• Table 18 Global Clinical Trial Management System Market Size, by Country/Region, 2021-2030 (USD Million)
• Table 19 North America: Clinical Trial Management System Market Size, by Country, 2021-2030 (USD Million)
• Table 20 North America: Clinical Trial Management System Market Size, by Component, 2021-2030 (USD Million)
• Table 21 North America: Clinical Trial Management System Market Size, by Type, 2021-2030 (USD Million)
• Table 22 North America: Clinical Trial Management System Market Size, by Mode of Delivery, 2021-2030 (USD Million)
• Table 23 North America: Clinical Trial Management System Market Size, by End User, 2021-2030 (USD Million)
• Table 24 U.S.: Clinical Trial Management System Market Size, by Component, 2021-2030 (USD Million)
• Table 25 U.S.: Clinical Trial Management System Market Size, by Type, 2021-2030 (USD Million)
• Table 26 U.S.: Clinical Trial Management System Market Size, by Mode of Delivery, 2021-2030 (USD Million)
• Table 27 U.S.: Clinical Trial Management System Market Size, by End User, 2021-2030 (USD Million)
• Table 28 Canada: Clinical Trial Management System Market Size, by Component, 2021-2030 (USD Million)
• Table 29 Canada: Clinical Trial Management System Market Size, by Type, 2021-2030 (USD Million)
• Table 30 Canada: Clinical Trial Management System Market Size, by Mode of Delivery, 2021-2030 (USD Million)
• Table 31 Canada: Clinical Trial Management System Market Size, by End User, 2021-2030 (USD Million)
• Table 32 Europe: Clinical Trial Management System Market Size, by Country, 2021-2030 (USD Million)
• Table 33 Europe: Clinical Trial Management System Market Size, by Component, 2021-2030 (USD Million)
• Table 34 Europe: Clinical Trial Management System Market Size, by Type, 2021-2030 (USD Million)
• Table 35 Europe: Clinical Trial Management System Market Size, by Mode of Delivery, 2021-2030 (USD Million)
• Table 36 Europe: Clinical Trial Management System Market Size, by End User, 2021-2030 (USD Million)
• Table 37 Germany: Clinical Trial Management System Market Size, by Component, 2021-2030 (USD Million)
• Table 38 Germany: Clinical Trial Management System Market Size, by Type, 2021-2030 (USD Million)
• Table 39 Germany: Clinical Trial Management System Market Size, by Mode of Delivery, 2021-2030 (USD Million)
• Table 40 Germany: Clinical Trial Management System Market Size, by End User, 2021-2030 (USD Million)
• Table 41 France: Clinical Trial Management System Market Size, by Component, 2021-2030 (USD Million)
• Table 42 France: Clinical Trial Management System Market Size, by Type, 2021-2030 (USD Million)
• Table 43 France: Clinical Trial Management System Market Size, by Mode of Delivery, 2021-2030 (USD Million)
• Table 44 France: Clinical Trial Management System Market Size, by End User, 2021-2030 (USD Million)
• Table 45 U.K.: Clinical Trial Management System Market Size, by Component, 2021-2030 (USD Million)
• Table 46 U.K.: Clinical Trial Management System Market Size, by Type, 2021-2030 (USD Million)
• Table 47 U.K.: Clinical Trial Management System Market Size, by Mode of Delivery, 2021-2030 (USD Million)
• Table 48 U.K.: Clinical Trial Management System Market Size, by End User, 2021-2030 (USD Million)
• Table 49 Italy: Clinical Trial Management System Market Size, by Component, 2021-2030 (USD Million)
• Table 50 Italy: Clinical Trial Management System Market Size, by Type, 2021-2030 (USD Million)
• Table 51 Italy: Clinical Trial Management System Market Size, by Mode of Delivery, 2021-2030 (USD Million)
• Table 52 Italy: Clinical Trial Management System Market Size, by End User, 2021-2030 (USD Million)
• Table 53 Spain: Clinical Trial Management System Market Size, by Component, 2021-2030 (USD Million)
• Table 54 Spain: Clinical Trial Management System Market Size, by Type, 2021-2030 (USD Million)
• Table 55 Spain: Clinical Trial Management System Market Size, by Mode of Delivery, 2021-2030 (USD Million)
• Table 56 Spain: Clinical Trial Management System Market Size, by End User, 2021-2030 (USD Million)
• Table 57 RoE: Clinical Trial Management System Market Size, by Component, 2021-2030 (USD Million)
• Table 58 RoE: Clinical Trial Management System Market Size, by Type, 2021-2030 (USD Million)
• Table 59 RoE: Clinical Trial Management System Market Size, by Mode of Delivery, 2021-2030 (USD Million)
• Table 60 RoE: Clinical Trial Management System Market Size, by End User, 2021-2030 (USD Million)
• Table 61 Asia-Pacific: Clinical Trial Management System Market Size, by Country, 2021-2030 (USD Million)
• Table 62 Asia-Pacific: Clinical Trial Management System Market Size, by Component, 2021-2030 (USD Million)
• Table 63 Asia-Pacific: Clinical Trial Management System Market Size, by Type, 2021-2030 (USD Million)
• Table 64 Asia-Pacific: Clinical Trial Management System Market Size, by Mode of Delivery, 2021-2030 (USD Million)
• Table 65 Asia-Pacific: Clinical Trial Management System Market Size, by End User, 2021-2030 (USD Million)
• Table 66 China: Clinical Trial Management System Market Size, by Component, 2021-2030 (USD Million)
• Table 67 China: Clinical Trial Management System Market Size, by Type, 2021-2030 (USD Million)
• Table 68 China: Clinical Trial Management System Market Size, by Mode of Delivery, 2021-2030 (USD Million)
• Table 69 China: Clinical Trial Management System Market Size, by End User, 2021-2030 (USD Million)
• Table 70 Japan: Clinical Trial Management System Market Size, by Component, 2021-2030 (USD Million)
• Table 71 Japan: Clinical Trial Management System Market Size, by Type, 2021-2030 (USD Million)
• Table 72 Japan: Clinical Trial Management System Market Size, by Mode of Delivery, 2021-2030 (USD Million)
• Table 73 Japan: Clinical Trial Management System Market Size, by End User, 2021-2030 (USD Million)
• Table 74 India: Clinical Trial Management System Market Size, by Component, 2021-2030 (USD Million)
• Table 75 India: Clinical Trial Management System Market Size, by Type, 2021-2030 (USD Million)
• Table 76 India: Clinical Trial Management System Market Size, by Mode of Delivery, 2021-2030 (USD Million)
• Table 77 India: Clinical Trial Management System Market Size, by End User, 2021-2030 (USD Million)
• Table 78 Rest of Asia-Pacific: Clinical Trial Management System Market Size, by Component, 2021-2030 (USD Million)
• Table 79 Rest of Asia-Pacific: Clinical Trial Management System Market Size, by Type, 2021-2030 (USD Million)
• Table 80 Rest of Asia-Pacific: Clinical Trial Management System Market Size, by Mode of Delivery, 2021-2030 (USD Million)
• Table 81 Rest of Asia-Pacific: Clinical Trial Management System Market Size, by End User, 2021-2030 (USD Million)
• Table 82 Latin America: Clinical Trial Management System Market Size, by Country, 2021-2030 (USD Million)
• Table 83 Latin America: Clinical Trial Management System Market Size, by Component, 2021-2030 (USD Million)
• Table 84 Latin America: Clinical Trial Management System Market Size, by Type, 2021-2030 (USD Million)
• Table 85 Latin America: Clinical Trial Management System Market Size, by Mode of Delivery, 2021-2030 (USD Million)
• Table 86 Latin America: Clinical Trial Management System Market Size, by End User, 2021-2030 (USD Million)
• Table 87 Brazil: Clinical Trial Management System Market Size, by Component, 2021-2030 (USD Million)
• Table 88 Brazil: Clinical Trial Management System Market Size, by Type, 2021-2030 (USD Million)
• Table 89 Brazil: Clinical Trial Management System Market Size, by Mode of Delivery, 2021-2030 (USD Million)
• Table 90 Brazil: Clinical Trial Management System Market Size, by End User, 2021-2030 (USD Million)
• Table 91 Mexico: Clinical Trial Management System Market Size, by Component, 2021-2030 (USD Million)
• Table 92 Mexico: Clinical Trial Management System Market Size, by Type, 2021-2030 (USD Million)
• Table 93 Mexico: Clinical Trial Management System Market Size, by Mode of Delivery, 2021-2030 (USD Million)
• Table 94 Mexico: Clinical Trial Management System Market Size, by End User, 2021-2030 (USD Million)
• Table 95 Rest of Latin America: Clinical Trial Management System Market Size, by Component, 2021-2030 (USD Million)
• Table 96 Rest of Latin America: Clinical Trial Management System Market Size, by Type, 2021-2030 (USD Million)
• Table 97 Rest of Latin America: Clinical Trial Management System Market Size, by Mode of Delivery, 2021-2030 (USD Million)
• Table 98 Rest of Latin America: Clinical Trial Management System Market Size, by End User, 2021-2030 (USD Million)
• Table 99 Middle East & Africa: Clinical Trial Management System Market Size, by Component, 2021-2030 (USD Million)
• Table 100 Middle East & Africa: Clinical Trial Management System Market Size, by Type, 2021-2030 (USD Million)
• Table 101 Middle East & Africa: Clinical Trial Management System Market Size, by Mode of Delivery, 2021-2030 (USD Million)
• Table 102 Middle East & Africa: Clinical Trial Management System Market Size, by End User, 2021-2030 (USD Million)
• Table 103 Recent Developments, by Company (2020-2022)

LIST OF FIGURES

• Figure 1 Research Process
• Figure 2 Key Secondary Sources
• Figure 3 Primary Research Techniques
• Figure 4 Key Executives Interviewed
• Figure 5 Breakdown of Primary Interviews (Supply-Side & Demand-Side)
• Figure 6 Market Size Estimation
• Figure 7 Global Clinical Trial Management System Size, by Component, 2024 Vs. 2030 (USD Million)
• Figure 8 Global Clinical Trial Management System Size, by Type, 2024 Vs. 2030 (USD Million)
• Figure 9 Global Clinical Trial Management System Size, by Mode of Delivery, 2024 Vs. 2030 (USD Million)
• Figure 10 Global Clinical Trial Management System Size, by End User, 2024 Vs. 2030 (USD Million)
• Figure 11 Clinical Trial Management System Market, by Region
• Figure 12 Market Dynamics
• Figure 13 Global Clinical Trial Management System Size, by Component, 2024 Vs. 2030 (USD Million)
• Figure 14 Global Clinical Trial Management System Size, by Type, 2024 Vs. 2030 (USD Million)
• Figure 15 Global Clinical Trial Management System Size, by Mode of Delivery, 2024 Vs. 2030 (USD Million)
• Figure 16 Global Clinical Trial Management System Size, by End User, 2024 Vs. 2030 (USD Million)
• Figure 17 Global Clinical Trial Management System Size, by Region, 2024 Vs. 2030 (USD Million)
• Figure 18 North America: Clinical Trial Management System Snapshot
• Figure 19 Europe: Clinical Trial Management System Snapshot
• Figure 20 Asia-Pacific: Clinical Trial Management System Snapshot
• Figure 21 Latin America: Clinical Trial Management System Snapshot
• Figure 22 Market Share Analysis: Clinical Trial Management System Market, 2022
• Figure 23 Oracle Corporation: Financial Overview, 2022
• Figure 24 LABORATORY CORPORATION OF AMERICA HOLDINGS: Financial Overview, 2022
• Figure 25 Wipro Limited: Financial Overview, 2022
• Figure 26 Datatrak International, Inc.: Financial Overview, 2022
• Figure 27 Dassault Systemes: Financial Overview, 2022
• Figure 28 Veeva Systems Inc.: Financial Overview, 2022
• Figure 29 IQVIA HOLDINGS INC.: Financial Overview, 2022

Clinical Trial Management System (CTMS) Market Size, Share, Forecast, & Trends Analysis by Component (Software, Service), Type (Enterprise, Site), Mode of Delivery (Web, Cloud, On-premise), End User (CRO, Pharmaceutical & Biotech) - Global Forecast to 2030

The clinical trial management system market is expected to grow at a CAGR of 13.5% from 2023 to 2030 to reach $3.59 billion by 2030.

Succeeding extensive secondary and primary research and in-depth analysis of the clinical trial management system market scenario, the report comprises the analysis of key industry drivers, restraints, challenges, and opportunities. A surge in the number of clinical trials, increasing adoption of healthcare IT, and rising government support are the factors driving the market growth. Furthermore, increasing the adoption of AI-based CTMS will likely offer better growth opportunities for market expansion. Moreover, the growing trend of integrated CTMS solutions is expected to support market growth. However, the lack of skilled healthcare professionals to handle advanced digital solutions poses a major challenge to the growth of the CTMS market.

The report offers a competitive landscape based on an extensive assessment of the product portfolio offerings, geographic presences, and key strategic developments adopted by leading market players in the industry over four years (2020-2023). The key players operating in the global clinical trial management system (CTMS) market are Oracle Corporation (U.S.), SimpleTrials (U.S.), LABORATORY CORPORATION OF AMERICA HOLDINGS (U.S.), Wipro Limited (India), Advarra, Inc. (U.S.), RealTime Software Solutions, LLC (U.S.), Datatrak International, Inc. (U.S.), Clario (U.S.), Dassault Systemes (France), Veeva Systems Inc. (U.S.), PHARMASEAL (U.K.), MasterControl Inc. (U.S.), Calyx (U.S.), IQVIA HOLDINGS INC. (U.S.), and DSG, Inc. (U.S.) among others.

Based on component, the software segment is expected to account for the largest share of the market in 2023. The factors contributing to the largest share of the market are ease in establishing regulatory compliance in clinical trials, rising research & development expenditure, and effective management of clinical trials leading to increased adoption of the clinical trial management system (CTMS).

Based on type, the market is segmented into enterprise-based and site-based CTMS. The enterprise-based segment is expected to account for the largest share of the market in 2023, owing to advantages such as end-to-end insights into operational activities, reduction in cost and investment, and adaption to advanced processes due to control and connection within the organization.

Based on end user, the market is segmented into pharmaceutical & biotechnology companies, medical device companies, contract research organizations, and other end users. The contract research organization segment is expected to account for the largest share of the market in 2023. Companies tend to outsource their clinical trial operations as they are complex and require time and investment. The large share can be attributed to the increased outsourcing of clinical trials by various healthcare stakeholders, including pharmaceutical & biotechnology companies, medical device manufacturers, animal health companies, and a few academic institutes.

An in-depth analysis of the geographical scenario of the global clinical trial management system (CTMS) market provides detailed qualitative and quantitative insights into the five major geographies (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) along with the coverage of major countries in each region.

Asia-Pacific is estimated to grow at the highest CAGR during the forecast period. Increasing outsourcing of clinical trials by major and minor stakeholders, the rising number of clinical trials in the region, and the availability of a large patient pool drive the demand for clinical trial management systems (CTMS).

Scope of the Report:

Global Clinical Trial Management System (CTMS) Market, by Component

• Software
• Service

Global Clinical Trial Management System (CTMS) Market, by Type

• Enterprise-based CTMS
• Site-based CTMS

Global Clinical Trial Management System (CTMS) Market, by Mode of Delivery

• Web-based CTMS
• Cloud-based CTMS
• On-premise CTMS

Global Clinical Trial Management System (CTMS) Market, by End User

• Contract Research Organizations (CROs)
• Pharmaceutical & Biotechnology Companies
• Medical Device Companies
• Other End Users

(Note: Other end users include hospitals, academic institutions, and animal health companies, among others)

Global Clinical Trial Management System (CTMS) Market, by Geography

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Rest of Europe (RoE)
• Asia-Pacific (APAC)
  • China
  • Japan
  • India
  • Rest of APAC (RoAPAC)
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America (RoLATAM)
• Middle East & Africa

TABLE OF CONTENTS

1. Introduction

• 1.1. Market Definition
• 1.2. Market Ecosystem
• 1.3. Currency
• 1.4. Key Stakeholders

2. Research Methodology

• 2.1. Research Process
• 2.2. Data Collection & Validation
  • 2.2.1. Secondary Research
  • 2.2.2. Primary Research
• 2.3. Market Assessment
  • 2.3.1. Market Size Estimation
    • 2.3.1.1. Bottom-up Approach
    • 2.3.1.2. Top-down Approach
    • 2.3.1.3. Growth Forecast
  • 2.3.2. Market Share Analysis
• 2.4. Assumptions for this Study
• 2.5. Limitations for the Study

3. Executive Summary

4. Market Insights

• 4.1. Introduction
• 4.2. Drivers
  • 4.2.1. Surge in Number of Clinical Trials
  • 4.2.2. Increasing Adoption of Healthcare IT Solutions
  • 4.2.3. Rising Government Support
• 4.3. Restraints
  • 4.3.1. Budget Constraints
  • 4.3.2. Concerns Over Data Privacy & Security
• 4.4. Opportunities
  • 4.4.1. Artificial Intelligence (AI) Based CTMS
• 4.5. Challenges
  • 4.5.1. Unavailability of Skilled Professionals
• 4.6. Impact of COVID-19 on the CTMS Market
• 4.7. Trend: Inclination of Companies Towards Integrated CTMS Solutions

5. Clinical Trial Management System (CTMS) Market, by Component

• 5.1. Introduction
• 5.2. Software
• 5.3. Service

6. Clinical Trial Management System (CTMS) Market, by Type

• 6.1. Introduction
• 6.2. Enterprise-based
• 6.3. Site-based

7. Clinical Trial Management System (CTMS) Market, by Mode of Delivery

• 7.1. Introduction
• 7.2. Web-based CTMS
• 7.3. Cloud-based CTMS
• 7.4. On-premise CTMS

8. Clinical Trial Management System (CTMS) Market, by End User

• 8.1. Introduction
• 8.2. Contract Research Organizations (CROs)
• 8.3. Pharmaceutical & Biotechnology Companies
• 8.4. Medical Device Companies
• 8.5. Other End Users

(Note: Other end users include hospitals, academic Institutions, and animal health companies, among others)

9. Clinical Trial Management System (CTMS) Market, by Geography

• 9.1. Introduction
• 9.2. North America
  • 9.2.1. U.S.
  • 9.2.2. Canada
• 9.3. Europe
  • 9.3.1. Germany
  • 9.3.2. France
  • 9.3.3. U.K.
  • 9.3.4. Italy
  • 9.3.5. Spain
  • 9.3.6. Rest of Europe (RoE)
• 9.4. Asia-Pacific
  • 9.4.1. Japan
  • 9.4.2. China
  • 9.4.3. India
  • 9.4.4. Rest of Asia-Pacific (RoAPAC)
• 9.5. Latin America
  • 9.5.1. Brazil
  • 9.5.2. Mexico
  • 9.5.3. Rest of Latin America
• 9.6. Middle East & Africa

10. Competitive Landscape

• 10.1. Introduction
• 10.2. Key Growth Strategies
• 10.3. Market Share Analysis (2022)

11. Company Profiles (Business Overview, Financial Snapshot, Product Portfolio, and Strategic Developments)

• 11.1. Oracle Corporation (U.S.)
• 11.2. SimpleTrials (U.S.)
• 11.3. LABORATORY CORPORATION OF AMERICA HOLDINGS (U.S.)
• 11.4. Wipro Limited (India)
• 11.5. Advarra, Inc. (U.S.)
• 11.6. RealTime Software Solutions, LLC (U.S.)
• 11.7. Datatrak International, Inc. (U.S.)
• 11.8. Clario (U.S.)
• 11.9. Dassault Systemes (France)
• 11.10. Veeva Systems Inc. (U.S.)
• 11.11. PHARMASEAL (U.K.)
• 11.12. MasterControl Inc. (U.S.)
• 11.13. Calyx (U.S.)
• 11.14. IQVIA HOLDINGS INC. (U.S.)
• 11.15. DSG, Inc. (U.S.)
• 11.16. Other Companies

12. Appendix

• 12.1. Questionnaire
• 12.2. Available Customization